Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study
Lindsey R. Baden(Brigham and Women's Hospital), Hong‐Van Tieu(New York Blood Center), Hanneke Schuitemaker(Johnson & Johnson (Israel)), Lauren Peter(Beth Israel Deaconess Medical Center), Colleen Kelly, Srilatha Edupuganti(Emory University), Magda Sobieszczyk(Columbia University), Stephen R. Walsh(Beth Israel Deaconess Medical Center), Susan Buchbinder(University of California, San Francisco), Paul Goepfert(University of Maryland, Baltimore), Etienne Karita(Rwanda Biomedical Center), Lorenz Scheppler(Janssen (Belgium)), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Johannes P. M. Langedijk(Janssen (Netherlands)), Michal Sarnecki(Janssen (Switzerland)), Georgia D. Tomaras(National Institutes of Health), Karen Buleza, Zelda Euler, Dimitri Goedhart, Nadine Rouphael(Emory University), Guido Ferrari(Duke University), Julie A. Ake(Walter Reed Army Institute of Research), Dan H. Barouch(Beth Israel Deaconess Medical Center), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Lawrence Corey(Fred Hutch Cancer Center), Trevor A. Crowell(Henry M. Jackson Foundation), Ian Frank(Norwegian Womens Public Health Association), Maria Grazia Pau, Daniel J Stieh(Janssen (Netherlands)), Merlin L. Robb(University of Maryland, Baltimore), Philipp Mann(Fred Hutch Cancer Center), Katleen Callewaert(Janssen (Belgium)), Frank Wegmann(Janssen (Netherlands)), M. Juliana McElrath(Fred Hutch Cancer Center), Steven Nijs(Janssen (Netherlands)), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Ken Mayer(Fenway Health), Frank Tomaka(Janssen (United States)), David C. Montefiori(Duke University), Michael C. Keefer(University of Rochester Medical Center), Kristen W. Cohen(Moderna Therapeutics (United States))
Cited by 91
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k